Committee

Executive Members


Chairman Naoya Fujita (Cancer Chemotherapy Ctr.)
General Hiroyuki Seimiya (Cancer Chemotherapy Ctr.)
Finance Shunji Takahashi (Cancer Inst. Hospital)
Makoto Nishio (Cancer Inst. Hospital)
Program Shingo Dan (Cancer Chemotherapy Ctr.)
Ryohei Katayama (Cancer Chemotherapy Ctr.)

Special Advisor

Mitsuaki Yoshida (Cancer Chemotherapy Ctr., Former Chairman of ISCC)
Saburo Sone (Tokushima Municipal Hospital)

Committee Members

North America
Bruce A. Chabner (MGH Cancer Ctr., US)
Ryan B. Corcoran (MGH Cancer Ctr., US)
Ross L. Levine (Memorial Sloan Kettering Cancer Ctr., US)
Yves G. Pommier (NCI, US)
Lillian L. Siu (Univ. Toronto, Canada)

Europe
Martijn Lolkema (Erasmus MC' Cancer Inst., Netherlands)
Jaap Verweij (Erasmus Univ. Medical Ctr., Netherlands)
Paul Workman (Inst. Cancer Res., UK)

Japan
Keisuke Aiba (Todachuo General Hospital)
Yataro Daigo (Shiga Univ. Med. Sci.)
Shingo Dan (Cancer Chemotherapy Ctr.)
Toshihiko Doi (National Cancer Ctr., CPOT)
Naoya Fujita (Cancer Chemotherapy Ctr.)
Yasuhiro Fujiwara (PMDA)
Masahiro Fukuoka (Izumi Hospital)
Noriko Gotoh (Kanazawa Univ.)
Kiyohiko Hatake (Akasaka Sanno Med. Ctr.)
Shigeo Horie (Juntendo Univ.)
Takeshi Imamura (Ehime Univ.)
Kengo Inoue (Pharma Valley Ctr.)
Chikashi Ishioka (Tohoku Univ.)
Hideaki Kakeya (Kyoto Univ.)
Ryohei Katayama (Cancer Chemotherapy Ctr.)
Manabu Kawada (Inst. Microbial Chem.)
Shinya Kimura (Saga Univ.)
Norio Komatsu (Juntendo Univ.)
Mineo Kurokawa (Univ. Tokyo)
Tetsuo Mashima (Cancer Chemotherapy Ctr.)
Hironobu Minami (Kobe Univ.)
Tetsuya Mitsudomi (Kinki Univ.)
Kohei Miyazono (Univ. Tokyo)
Tamio Mizukami (Nagahama Inst. of Bio-Science & Technology)
Isao Momose (Inst. Microbial Chem.)
Morito Monden (Sakai City Hospital)
Kei Muro (Aichi Cancer Ctr. Hospital)
Mikihiko Naito (Univ. of Tokyo)
Hiroyuki Nakamura (Tokyo Inst. Technol.)
Yusuke Nakamura (NIBIO)
Tomoki Naoe (NHO Nagoya Medical Center)
Yoshiro Niitsu (Tokushukai Group)
Hiroyoshi Nishikawa (National Cancer Ctr.)
Kazuto Nishio (Kinki Univ.)
Makoto Nishio (Cancer Inst. Hospital)
Yasuhiko Nishioka (Tokushima Univ.)
Tomokazu Ohishi (Inst. Microbial Chem.)
Atsushi Ohtsu (National Cancer Ctr. )
Isamu Okamoto (Kyushu Univ.)
Mayumi Ono (St. Mary's College)
Hiroyuki Osada (RIKEN)
Masanobu Oshima (Kanazawa Univ.)
Toshiaki Saeki (Saitama Med. School)
Nagahiro Saijo (Yukokai Akihabara Meguro Medical Clinic)
Shuichi Sakamoto (Inst. Microbial Chem.)
Yasutsuna Sasaki (Showa Univ.)
Hideyuki Saya (Fujita Cancer Ctr.)
Hiroyuki Seimiya (Cancer Chemotherapy Ctr.)
Yasuhiro Shimada (Kochi Health Sciences Ctr.)
Siro Simizu (Keio Univ.)
Yoshihiro Sowa (Kyoto Pref. Univ. Med.)
Yoshikazu Sugimoto (Keio Univ.)
Hidetoshi Tahara (Hiroshima Univ.)
Shunji Takahashi (Cancer Inst. Hospital)
Tomohide Tamura (St. Luke's International Hospital)
Tadatsugu Taniguchi (Univ. Tokyo)
Hiroaki Taniguchi (Tokyo Inst. Technol.)
Yasuhito Terui (Saitama Med. Univ.)
Akihiro Tomida (Cancer Chemotherapy Ctr.)
Masahiro Tsuboi (National Cancer Ctr. )
Kosuke Watari (Kyushu Univ.)
Yoshimasa Uehara (Iwate Med. Univ.)
Kazuo Umezawa (Aichi Med. Univ.)
Noriko Usui (Jikei Univ.)
Tatsuro Watanabe (Saga Univ.)
Kazuhito Yamamoto (Aichi Cancer Ctr. Hospital)
Ken Yamaguchi (Shizuoka Cancer Ctr.)
Kensei Yamaguchi (Cancer Inst. Hospital)
Takao Yamori (Teikyo Univ.)
Seiji Yano (Kanazawa Univ.)
Minoru Yoshida (RIKEN)

Advisory Committee Member

Stanley B. Kaye (The Royal Marsden Hospital, U.K.)
Herbert M. Pinedo (VUmc Cancer Ctr. Amsterdam, Netherlands)
Mitsuyuki Abe (Hyogo Ion Beam Med. Ctr.)
Shiro Akinaga (Nano Carrier Co., Ltd.)
Tadao Kakizoe (Jpn. Cancer Society)
Tomoyuki Kitagawa (Cancer Institute)
Minoru Kurihara (Tokyo Cooperative Oncology Group)
Toru Masaoka (Osaka Medical Ctr. for Cancer and Cardiovascular Diseases)
Toshifusa Nakajima (Cancer Institute Hospital)
Makoto Ogawa (Aichi Cancer Ctr.)
Ryuzo Ohno (Aichi Cancer Ctr.)
Hidehiko Saito (Nagoya Central Hospital)
Kiyohiko Sakamoto (Tohoku Univ.)
Motoharu Seiki (Univ. Tokyo)
Masanori Shimoyama (National Cancer Ctr.)
Koichi Shudo (Itsuu Laboratory)
Keizo Sugimachi (Onga Hospital)
Tetsuo Taguchi (Japan Society for Cancer Chemotherapy)
Masaaki Terada (National Cancer Ctr.)
Kensei Tobinai (National Cancer Ctr. Hospital)
Takeshi Tominaga (Showa Univ.)
Ryuzo Ueda (Aichi Med. Univ.)
Shigeaki Yoshida (Aomori Prefectural Central Hospital)

Corporate Members

Takashi Shimamoto (MSD K.K.)
Masahiro Esaki (Kyowa Kirin Co., Ltd.)
Taku Yoshida (Astellas Pharma Inc.)
Yuki Yamashita (Bristol-Myers Squibb K.K.)
Mika Sakurai (Chugai Pharmaceutical Co., Ltd.)
Yoshihiko Fujisaki (Daiichi Sankyo Co., Ltd.)
Akira Yokoi (Eisai Co., Ltd.)
Takeshi Mera (Nippon Boehringer Ingelheim Co., Ltd)
Ryohei Kozaki (Ono Pharmaceutical Co., Ltd.)
Koji Wakayama (Sanofi K.K.)
Jumpei Soeda (Takeda Pharmaceutical Co., Ltd.)
Tomoji Miyazaki (Yakult Honsha Co., Ltd.)
Kenji Suzuki (Taiho Pharmaceutical Co., Ltd.)

Secretariat

Ritsuko Mihara (Cancer Chemotherapy Ctr.)

Page Top